v3.26.1
Revenue Recognition - Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss [Line Items]    
Revenue $ 5,100,315 $ 4,107,494
Cost of revenue 2,289,537 1,284,375
Gross profit $ 2,810,779  
Gross Profit % 54.73%  
Assets $ 4,488,694 3,821,429
Net income (loss) (7,812,409) $ (5,562,971)
Global Stem Cells Group [Member]    
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss [Line Items]    
Revenue 5,100,315  
Cost of revenue 2,289,537  
Gross profit $ 2,810,778  
Gross Profit % 54.73%  
Assets $ 2,718,911  
Net income (loss) (742,221)  
Meso Numismatics [Member]    
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss [Line Items]    
Revenue  
Cost of revenue  
Gross profit  
Gross Profit % 0.00%  
Assets $ 1,769,783  
Net income (loss) $ (7,070,188)